Skip to Content

T29 (Carbamazepine Extended-Release 400 mg)

Pill with imprint T29 is White, Capsule-shape and has been identified as Carbamazepine Extended-Release 400 mg. It is supplied by Taro Pharmaceutical Industries Ltd..

Carbamazepine is used in the treatment of trigeminal neuralgia; bipolar disorder; schizoaffective disorder; epilepsy and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for T29

Carbamazepine extended-release 400 mg T29
Carbamazepine extended-release 400 mg T29  Front
Carbamazepine extended-release 400 mg T29  Back
Carbamazepine extended-release 400 mg T29

Carbamazepine Extended-Release

Imprint
T29
Strength
400 mg
Color
White
Size
17.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Dibenzazepine anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Taro Pharmaceutical Industries Ltd.
Inactive Ingredients
corn starch, diethyl phthalate, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium starch glycolate type A potato

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
51672-4125 Taro Pharmaceuticals USA, Inc.
54868-6074 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Related Images for "T29"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.